A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRS

Inclusion Criteria: * The participant and/or parent(s)/legal guardian(s) are willing and able to comply with the study protocol. * In accordance with regional/local laws and regulations, * a. the parent(s)/legal guardian(s) has given signed informed, dated consent; and the participant has * b.given written assent, if applicable, to participate in the study (for participants between 7 to 12 years) * Age: Participant must be aged greater than or equal to (\>=) 3 months to 12 years, of either gender. * Participants who are otherwise healthy and presenting with suspected CAP. * For participants clinically suspected of CAP, at least 3 of the following 4 criteria are applicable: * a) History of productive cough and/or shortness of breath. * b)Fever greater than (\>)38.5 degree Celsius (○C) (Axillary temperature) * c) Tachypnea as defined by Respiratory rate (RR) \>= 50 breaths/minute in children up to 11 months RR \>= 40 breaths/minute in children from 12 months onwards * d) Chest X-Ray with shadow or lobar condensation, unilateral or bilateral. For participants of ABRS: * The participant and/or parent(s)/legal guardian(s) are willing and able to comply with the study protocol. * In accordance with regional/local laws and regulations, * a..The parent(s)/legal guardian(s) has given signed informed, dated consent; and the participant has * b. given written assent, if applicable, to participate in the study (for participants between 7 to 12 years). * Age: Participant must be betwee…